Biocept bolsters board of directors and names Samuel D Riccitelli as new chairman

Biocept Inc (NASDAQ:BIOC) (FRA:B003) has expanded its board of directors to nine members from seven and named director since 2020 Samuel D Riccitelli as the company's new chairman as the diagnostics group builds on recent momentum. Experienced financial executives Linda Rubinstein and Antonino Morales become new directors with immediate effect. READ: Biocept partners with Quest Diagnostics to provide its Target Selector NGS-based liquid biopsy testing for lung cancer Meanwhile, Riccitelli succeeds long-time chair David Hale and interim Chair M Faye Wilson, both of whom remain directors, noted Biocept. Riccitelli, who has over 35 years' of healthcare industry experience, said he was "honored" by the appointment. "The company is making remarkable strides in oncology diagnostics, especially in neuro-oncology with the recent launch of the CNSide cerebrospinal fluid assay to aid in the identification and management of brain metastases," he said. "This esteemed group of directors, now with the addition of Linda and Antonino, is committed to furthering Biocept’s strategic growth initiatives and advancing its molecular diagnostic services, with the ultimate goal of helping to improve clinical outcomes for patients with cancer." Michael Nall, CEO of Biocept, said Riccitelli would provide "strong governance, leadership and insight" while "Linda and Antonino bring fresh perspectives, diverse backgrounds and a wealth of valuable experience to the board". "We are especially grateful to David Hale for serving as our previous chairman and to Faye Wilson for stepping up as interim chair," he added. Rubinstein has over 30 years of financial and capital markets experience in life sciences and investment banking. Since 2010 she has been a partner at FLG Partners, where she provides financial and strategic consulting services to life science and other companies such as Apexigen, ArmaGen, Five Prime, Kezar Life Sciences, Ingenuity Systems, iPierian and True North. Morales has over three decades of international executive leadership experience in financial consulting, business development, operations, regulatory compliance and risk management. Most recently he was president and CEO of Apoyo Financiero Inc, a California based community development financial institution. Contact the author at giles@proactiveinvestors.com